Difference between revisions of "Alpha-2 plasmin inhibitor (FXIIIa)"
(New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...) |
m |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
− | |||
− | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
− | | | + | | Alpha-2 plasmin inhibitor |
|- | |- | ||
| Synonyms | | Synonyms | ||
Line 49: | Line 47: | ||
reactivities: Q2 > Q21 > Q419 > Q447 | reactivities: Q2 > Q21 > Q419 > Q447 | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:FXIIIa|*]] | [[Category:FXIIIa|*]] |
Latest revision as of 11:05, 10 March 2015
Alpha-2 plasmin inhibitor (FXIIIa) | |
---|---|
Substrate peptide name | Alpha-2 plasmin inhibitor |
Synonyms | Alpha-2-antiplasmin |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; plasma |
Swissprot ID | P08697 |
Reactive glutamines | Q2 |
Reactive lysines | - |
Substrate sequence | NQEEVSP |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:10958788 |
Notes | 4 of 35 Q residues were labeled with the following
reactivities: Q2 > Q21 > Q419 > Q447 |